标题
Integrins as attractive targets for cancer therapeutics
作者
关键词
-
出版物
Acta Pharmaceutica Sinica B
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-04-14
DOI
10.1016/j.apsb.2021.01.004
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Extracellular Vesicles from Cancer-Associated Fibroblasts Containing Annexin A6 Induces FAK-YAP Activation by Stabilizing β1 Integrin, Enhancing Drug Resistance
- (2020) Tomoyuki Uchihara et al. CANCER RESEARCH
- Dual-targeting nanovesicles enhance specificity to dynamic tumor cells in vitro and in vivo via manipulation of αvβ3-ligand binding
- (2020) Yang Song et al. Acta Pharmaceutica Sinica B
- EGFR and αvβ6 as Promising Targets for Molecular Imaging of Cutaneous and Mucosal Squamous Cell Carcinoma of the Head and Neck Region
- (2020) Victor M. Baart et al. Cancers
- The functional role of integrins during intra- and extravasation within the metastatic cascade
- (2019) Greta Sökeland et al. Molecular Cancer
- Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance
- (2019) Jonathan Cooper et al. CANCER CELL
- CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies
- (2019) Lynsey M. Whilding et al. Cancers
- Integrins as biomechanical sensors of the microenvironment
- (2019) Jenny Z. Kechagia et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Clinical and Therapeutic Implications of Cancer Stem Cells
- (2019) Michael F. Clarke NEW ENGLAND JOURNAL OF MEDICINE
- Functional Redundancy between β1 and β3 Integrin in Activating the IR/Akt/mTORC1 Signaling Axis to Promote ErbB2-Driven Breast Cancer
- (2019) Tung Bui et al. Cell Reports
- Optimized functional and structural design of dual-target LMRAP, a bifunctional fusion protein with a 25-amino-acid antitumor peptide and GnRH Fc fragment
- (2019) Meng Li et al. Acta Pharmaceutica Sinica B
- PEP06 polypeptide 30 is a novel cluster-dissociating agent inhibiting v integrin/FAK/Src signaling in oral squamous cell carcinoma cells
- (2019) Gulnara Tuguzbaeva et al. Acta Pharmaceutica Sinica B
- Integrin alpha V beta 3 targeted dendrimer-rapamycin conjugate reduces fibroblast-mediated prostate tumor progression and metastasis
- (2018) Elliott E. Hill et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis
- (2018) Roberta Lugano et al. JOURNAL OF CLINICAL INVESTIGATION
- Accurate control of dual-receptor-engineered T cell activity through a bifunctional anti-angiogenic peptide
- (2018) Erhao Zhang et al. Journal of Hematology & Oncology
- TGFβ, Fibronectin and Integrin α5β1 Promote Invasion in Basal Cell Carcinoma
- (2018) François Kuonen et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The clinical efficacy and safety of paclitaxel combined with avastin for NSCLC patients diagnosed with malignant pleural effusion
- (2018) Zhen Wang et al. Revista da Associacao Medica Brasileira
- Discontinuous Schedule of Bevacizumab in Colorectal Cancer Induces Accelerated Tumor Growth and Phenotypic Changes
- (2018) Selma Becherirat et al. Translational Oncology
- Targeting the Tie2–αvβ3 integrin axis with bi-specific reagents for the inhibition of angiogenesis
- (2018) Tomer Shlamkovich et al. BMC BIOLOGY
- EGFL7 enhances surface expression of integrin α5β1 to promote angiogenesis in malignant brain tumors
- (2018) Nevenka Dudvarski Stanković et al. EMBO Molecular Medicine
- αvβ3 INTEGRIN MEDIATES RADIORESISTANCE OF PROSTATE CANCER CELLS THROUGH REGULATION OF SURVIVIN
- (2018) Tao Wang et al. MOLECULAR CANCER RESEARCH
- Integrin αvβ6 plays a bi-directional regulation role between colon cancer cells and cancer-associated fibroblasts
- (2018) Cheng Peng et al. BIOSCIENCE REPORTS
- Tissue-resident memory CD8+ T cells promote melanoma–immune equilibrium in skin
- (2018) Simone L. Park et al. NATURE
- Integrin trafficking in cells and tissues
- (2018) Paulina Moreno-Layseca et al. NATURE CELL BIOLOGY
- Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin β3–p38 MAPK signalling
- (2018) Siyang Wen et al. CANCER LETTERS
- The Interconnections between Autophagy and Integrin-Mediated Cell Adhesion
- (2017) Ariadne Vlahakis et al. JOURNAL OF MOLECULAR BIOLOGY
- Hypoxia Selectively Enhances Integrin α 5 β 1 Receptor Expression in Breast Cancer to Promote Metastasis
- (2017) Julia A. Ju et al. MOLECULAR CANCER RESEARCH
- Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer
- (2017) Arman Jahangiri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Novel production method of innovative antiangiogenic and antitumor small peptides in Escherichia coli
- (2017) Sarra Setrerrahmane et al. Drug Design Development and Therapy
- The complexity of integrins in cancer and new scopes for therapeutic targeting
- (2016) Hellyeh Hamidi et al. BRITISH JOURNAL OF CANCER
- Antagonizing Integrin 3 Increases Immunosuppression in Cancer
- (2016) X. Su et al. CANCER RESEARCH
- Enhanced therapeutic effect of an antiangiogenesis peptide on lung cancer in vivo combined with salmonella VNP20009 carrying a Sox2 shRNA construct
- (2016) Changhong Zhao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Mechanisms and regulation of endothelial VEGF receptor signalling
- (2016) Michael Simons et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- An integrin αvβ3 antagonistic modified peptide inhibits tumor growth through inhibition of the ERK and AKT signaling pathways
- (2016) Lirong Hu et al. ONCOLOGY REPORTS
- In vitro and in vivo activities of an antitumor peptide HM-3: A special dose-efficacy relationship on an HCT-116 xenograft model in nude mice
- (2016) Sitelbanat Yassin et al. ONCOLOGY REPORTS
- Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway
- (2016) Rayanah Barnawi et al. STEM CELLS
- αIIbβ3-integrin Ligands: Abciximab and Eptifibatide as Proapoptotic Factors in MCF-7 Human Breast Cancer Cells
- (2015) Joanna Kononczuk et al. CURRENT DRUG TARGETS
- Anti-tumor peptide AP25 decreases cyclin D1 expression and inhibits MGC-803 proliferation via phospho-extracellular signal-regulated kinase-, Src-, c-Jun N-terminal kinase-and phosphoinositide 3-kinase-associated pathways
- (2015) JIALIANG HU et al. Molecular Medicine Reports
- Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions
- (2014) Naveen S. Vasudev et al. ANGIOGENESIS
- Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progression
- (2014) Günter Eisele et al. JOURNAL OF NEURO-ONCOLOGY
- Therapeutic Targeting of Integrin αvβ6 in Breast Cancer
- (2014) Kate M. Moore et al. JNCI-Journal of the National Cancer Institute
- 1 Integrin Inhibition Elicits a Prometastatic Switch Through the TGF -miR-200-ZEB Network in E-Cadherin-Positive Triple-Negative Breast Cancer
- (2014) H. H. Truong et al. Science Signaling
- Flipping the Switch: Integrin Switching Provides Metastatic Competence
- (2014) A. Madamanchi et al. Science Signaling
- Molecular basis for the targeted binding of RGD-containing peptide to integrin αVβ3
- (2013) Yu-Ping Yu et al. BIOMATERIALS
- A Rare Population of CD24+ITGB4+Notchhi Cells Drives Tumor Propagation in NSCLC and Requires Notch3 for Self-Renewal
- (2013) Yanyan Zheng et al. CANCER CELL
- Altered Microenvironment Promotes Progression of Preinvasive Breast Cancer: Myoepithelial Expression of v 6 Integrin in DCIS Identifies High-risk Patients and Predicts Recurrence
- (2013) M. D. Allen et al. CLINICAL CANCER RESEARCH
- E-cadherin-integrin crosstalk in cancer invasion and metastasis
- (2013) M. Canel et al. JOURNAL OF CELL SCIENCE
- Targeted inactivation of β1 integrin induces β3 integrin switching, which drives breast cancer metastasis by TGF-β
- (2013) Jenny G. Parvani et al. MOLECULAR BIOLOGY OF THE CELL
- Cancer stem cells: The challenges ahead
- (2013) Jan Paul Medema NATURE CELL BIOLOGY
- Evaluation of the expression of stem cell markers in human breast cancer reveals a correlation with clinical progression and metastatic disease in ductal carcinoma
- (2013) TRACEY AMANDA MARTIN et al. ONCOLOGY REPORTS
- Validation of stem cell markers in clinical prostate cancer: α6-Integrin is predictive for non-aggressive disease
- (2013) A. Marije Hoogland et al. PROSTATE
- Integrin α5β1, the Fibronectin Receptor, as a Pertinent Therapeutic Target in Solid Tumors
- (2013) Florence Schaffner et al. Cancers
- Highly Invasive Melanoma Cells Activate the Vascular Endothelium via an MMP-2/Integrin αvβ5–Induced Secretion of VEGF-A
- (2012) Anna Desch et al. AMERICAN JOURNAL OF PATHOLOGY
- Phase Ib safety and pharmacokinetic study of volociximab, an anti-α5β1 integrin antibody, in combination with carboplatin and paclitaxel in advanced non-small-cell lung cancer
- (2012) B. Besse et al. ANNALS OF ONCOLOGY
- Regulation of adherens junctions by Rho GTPases and p120-catenin
- (2012) Andre Menke et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Integrin 5 1 Plays a Critical Role in Resistance to Temozolomide by Interfering with the p53 Pathway in High-Grade Glioma
- (2012) H. Janouskova et al. CANCER RESEARCH
- Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia
- (2012) S. J. Conley et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation
- (2011) Carlos Mas-Moruno et al. Anti-Cancer Agents in Medicinal Chemistry
- RGD-Modified Angiogenesis Inhibitor HM-3 Dose: Dual Function during Cancer Treatment
- (2011) Hanmei Xu et al. BIOCONJUGATE CHEMISTRY
- Receptor Tyrosine Kinases and TLR/IL1Rs Unexpectedly Activate Myeloid Cell PI3Kγ, A Single Convergent Point Promoting Tumor Inflammation and Progression
- (2011) Michael C. Schmid et al. CANCER CELL
- Combined Blockade of Integrin- 4 1 Plus Cytokines SDF-1 or IL-1 Potently Inhibits Tumor Inflammation and Growth
- (2011) M. C. Schmid et al. CANCER RESEARCH
- Volociximab in cancer
- (2011) Salah Almokadem et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- In Vivo Anti-Tumor Activity of Polypeptide HM-3 Modified by Different Polyethylene Glycols (PEG)
- (2011) Zhendong Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The interaction between caveolin-1 and Rho-GTPases promotes metastasis by controlling the expression of alpha5-integrin and the activation of Src, Ras and Erk
- (2011) E Arpaia et al. ONCOGENE
- Tumor-initiating stem cells of squamous cell carcinomas and their control by TGF- and integrin/focal adhesion kinase (FAK) signaling
- (2011) M. Schober et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of RGD-4C Position is More Important Than Disulfide Bonds on Antiangiogenic Activity of RGD-4C Modified Endostatin Derived Synthetic Polypeptide
- (2010) Runting Yin et al. BIOCONJUGATE CHEMISTRY
- Quantitative In vivo Imaging of the Effects of Inhibiting Integrin Signaling via Src and FAK on Cancer Cell Movement: Effects on E-cadherin Dynamics
- (2010) M. Canel et al. CANCER RESEARCH
- ADAM15 to α5β1 integrin switch in colon carcinoma cells: A late event in cancer progression associated with tumor dedifferentiation and poor prognosis
- (2010) Claire Toquet et al. INTERNATIONAL JOURNAL OF CANCER
- Angiogenesis drives psoriasis pathogenesis
- (2010) Regina Heidenreich et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer
- (2010) Anne-Marie C Dingemans et al. Molecular Cancer
- Cooperation between integrin ανβ3 and VEGFR2 in angiogenesis
- (2009) Payaningal R. Somanath et al. ANGIOGENESIS
- Studies of Poly(ethylene glycol) Modification of HM-3 Polypeptides
- (2009) Kang Zhou et al. BIOCONJUGATE CHEMISTRY
- Specific Cross-talk between Epidermal Growth Factor Receptor and Integrin αvβ5 Promotes Carcinoma Cell Invasion and Metastasis
- (2009) Jill M. Ricono et al. CANCER RESEARCH
- Transforming Growth Factor Induces Clustering of HER2 and Integrins by Activating Src-Focal Adhesion Kinase and Receptor Association to the Cytoskeleton
- (2009) S. E. Wang et al. CANCER RESEARCH
- Genetic and cell biological analysis of integrin outside-in signaling
- (2009) K. R. Legate et al. GENES & DEVELOPMENT
- Linking integrin conformation to function
- (2009) J. A. Askari et al. JOURNAL OF CELL SCIENCE
- Pharmacology of the Novel Antiangiogenic Peptide ATN-161 (Ac-PHSCN-NH2): Observation of a U-Shaped Dose-Response Curve in Several Preclinical Models of Angiogenesis and Tumor Growth
- (2008) F. Donate et al. CLINICAL CANCER RESEARCH
- Src and focal adhesion kinase as therapeutic targets in cancer
- (2008) Valerie G Brunton et al. CURRENT OPINION IN PHARMACOLOGY
- Integrin αvβ3-targeted cancer therapy
- (2008) Zhaofei Liu et al. DRUG DEVELOPMENT RESEARCH
- Rab-coupling protein coordinates recycling of α5β1 integrin and EGFR1 to promote cell migration in 3D microenvironments
- (2008) Patrick T. Caswell et al. JOURNAL OF CELL BIOLOGY
- Rac-dependent cyclin D1 gene expression regulated by cadherin- and integrin-mediated adhesion
- (2008) A. K. Fournier et al. JOURNAL OF CELL SCIENCE
- Environmental sensing through focal adhesions
- (2008) Benjamin Geiger et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- TGFβ-induced EMT requires focal adhesion kinase (FAK) signaling
- (2007) Carla Cicchini et al. EXPERIMENTAL CELL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started